NATIONAL PSORIASIS FOUNDATION for NATIONAL PSORIASIS FOUNDATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
S.358, Genetic Nondiscrimination Act S.358, Genetic Nondiscrimination Act: Title II: Prohibiting Employment Discrimination on the Basis of Genetic Information - (Sec. 202) Prohibits, as an unlawful employment practice, an employer, employment agency, labor organization, or joint labor-management committee from discriminating against an employee, individual, or member on the basis of genetic information, including: (1) for an employer, by failing to hire or discharging an employee or otherwise discriminating against an employee with respect to the compensation, terms, conditions, or privileges of employment; (2) for an employment agency, by failing or refusing to refer an individual for employment; (3) for a labor organization, by excluding or expelling a member from the organization; (4) for an employment agency, labor organization, or joint labor-management committee, by causing or attempting to cause an employer to discriminate against a member in violation of this Act; or (5) for an employer, labor organization, or joint labor-management committee, by discriminating against an individual in admission to, or employment in, any program established to provide apprenticeships or other training or retraining.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALYSSA BROWN | — |
| SHEILA RITTENBERG | — |
Medical/Disease Research/Clinical Labs MED
H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 101. EXPANSION OF BIOMEDICAL RESEARCH Directs the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to expand and intensify research on psoriasis and psoriatic arthritis. Directs NIAMS to coordinate with other National Institutes of Health (NIH) centers, institutes, and offices with respect to psoriasis and psoriatic arthritis research. Section 102. STRENGTHENING PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY Directs the Centers for Disease Control and Prevention (CDC), in collaboration with a national organization expert in the epidemiology of psoriasis and psoriatic arthritis, to establish a national psoriasis and psoriatic arthritis patient registry. Section 103. PSORIASIS AND PSORIATIC ARTHRITIS CO-MORBIDITIES CONDITIONS SUMMIT Directs the Department of Health and Human Services (HHS) to convene a summit of researchers, public health professionals, patient advocacy organizations, academic institutions, and Federal and State policymakers to provide a detailed overview of current efforts in psoriasis and psoriatic arthritis research, treatment, quality of life, and other such activities at the NIH, CDC, the Agency for Healthcare Research and Quality, the Substance Abuse and Mental Health Services Administration, and the Health Resources and Services Administration, and other federal agencies whose work involves psoriasis and psoriatic arthritis related co-morbidities. Requires a report to Congress not later than 180 days after the convening of summit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALYSSA BROWN | — |
| SHEILA RITTENBERG | — |
Health Issues HCR
Access to care for people with psoriasis and psoriatic arthritis H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 104. STUDY AND REPORT BY THE INSTITUTE OF MEDICINE Directs the HHS Secretary to enter into a contract with the Institute of Medicine (IOM) to conduct a study to evaluate and make recommendations to address the following: (1) The extent to which public and private insurers cover prescription medications and other treatments for psoriasis and psoriatic arthritis; (2) The payment structures, such as deductibles and co-payments, amounts and duration of the coverage and payments under health plans and their adequacy to cover the costs of providing ongoing care to patients with psoriasis and psoriatic arthritis; (3) Health plan and insurer coverage policies and practices and their impact on patient access to the best regimen and most appropriate care for their particular disease state.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALYSSA BROWN | — |
| SHEILA RITTENBERG | — |
Budget/Appropriations BUD
H.R.3043, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, Title 2, all provisions relating to National Institutes of Health and National Center for Health Statistics S.1710, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, Title 2, all provisions relating to National Institutes of Health and National Center for Health Statistics
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALYSSA BROWN | — |
| SHEILA RITTENBERG | — |
Insurance INS
S.358, Genetic Nondiscrimination Act S.358, Genetic Nondiscrimination Act Title: A bill to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. Title I: Genetic Nondiscrimination in Health Insurance - (Sec. 101) Amends the Employee Retirement Income Security Act of 1974 (ERISA) and the Public Health Service Act (PHSA) to specify that genetic information that an issuer of group health insurance may not establish as an enrollment eligibility factor includes information about a request for or receipt of genetic services by an individual or family member. Prohibits a group health plan or a health insurance issuer from: (1) adjusting premiums on the basis of genetic information; or (2) requesting or requiring an individual or a family member of such individual to undergo a genetic test.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALYSSA BROWN | — |
| SHEILA RITTENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.